Literature DB >> 9011580

In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.

M Bai1, S H Pearce, O Kifor, S Trivedi, U G Stauffer, R V Thakker, E M Brown, B Steinmann.   

Abstract

We characterized the in vivo, cellular and molecular pathophysiology of a case of neonatal hyperparathyroidism (NHPT) resulting from a de novo, heterozygous missense mutation in the gene for the extracellular Ca2+ (Ca2+(o))-sensing receptor (CaR). The female neonate presented with moderately severe hypercalcemia, markedly undermineralized bones, and multiple metaphyseal fractures. Subtotal parathyroidectomy was performed at 6 wk; hypercalcemia recurred rapidly but the bone disease improved gradually with reversion to an asymptomatic state resembling familial benign hypocalciuric hypercalcemia (FBHH). Dispersed parathyroid cells from the resected tissue showed a set-point (the level of Ca2+(o) half maximally inhibiting PTH secretion) substantially higher than for normal human parathyroid cells (approximately 1.8 vs. approximately 1.0 mM, respectively); a similar increase in set-point was observed in vivo. The proband's CaR gene showed a missense mutation (R185Q) at codon 185, while her normocalcemic parents were homozygous for wild type (WT) CaR sequence. Transient expression of the mutant R185Q CaR in human embryonic kidney (HEK293) cells revealed a substantially attenuated Ca2+(o)-evoked accumulation of total inositol phosphates (IP), while cotransfection of normal and mutant receptors showed an EC50 (the level of Ca2+(o) eliciting a half-maximal increase in IPs) 37% higher than for WT CaR alone (6.3+/-0.4 vs. 4.6+/-0.3 mM Ca2+(o), respectively). Thus this de novo, heterozygous CaR mutation may exert a dominant negative action on the normal CaR, producing NHPT and more severe hypercalcemia than typically seen with FBHH. Moreover, normal maternal calcium homeostasis promoted additional secondary hyperparathyroidism in the fetus, contributing to the severity of the NHPT in this case with FBHH.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9011580      PMCID: PMC507771          DOI: 10.1172/JCI119137

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

Review 1.  Severe primary hyperparathyroidism in a neonate having a parent with hypercalcemia: treatment by total parathyroidectomy and simultaneous heterotopic autotransplantation.

Authors:  Y Fujimoto; H Hazama; K Oku
Journal:  Surgery       Date:  1990-11       Impact factor: 3.982

2.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

Review 3.  Calcium-ion-sensing cell-surface receptors.

Authors:  E M Brown; M Pollak; C E Seidman; J G Seidman; Y H Chou; D Riccardi; S C Hebert
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

4.  Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia.

Authors:  Y H Chou; M R Pollak; M L Brandi; G Toss; H Arnqvist; A B Atkinson; S E Papapoulos; S Marx; E M Brown; J G Seidman
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

5.  Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation.

Authors:  M R Pollak; E M Brown; H L Estep; P N McLaine; O Kifor; J Park; S C Hebert; C E Seidman; J G Seidman
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

6.  Self limiting neonatal primary hyperparathyroidism associated with familial hypocalciuric hypercalcaemia.

Authors:  H Wilkinson; J James
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

7.  Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  N Janicic; Z Pausova; D E Cole; G N Hendy
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

8.  Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M R Pollak; E M Brown; Y H Chou; S C Hebert; S J Marx; B Steinmann; T Levi; C E Seidman; J G Seidman
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

9.  Neonatal primary hyperparathyroidism masked by vitamin D deficiency.

Authors:  K Meeran; M Husain; M Puccini; H Scott; C Dionisi-Vici; D R Harvey; J Lynn; R V Thakker
Journal:  Clin Endocrinol (Oxf)       Date:  1994-10       Impact factor: 3.478

10.  Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype.

Authors:  M R Pollak; Y H Chou; S J Marx; B Steinmann; D E Cole; M L Brandi; S E Papapoulos; F H Menko; G N Hendy; E M Brown
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  35 in total

Review 1.  Familial hypocalciuric hypercalcemia.

Authors:  D A Heath
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Calcium receptor and regulation of parathyroid hormone secretion.

Authors:  E M Brown
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 3.  Hypercalcemia in children and adolescents.

Authors:  Steven A Lietman; Emily L Germain-Lee; Michael A Levine
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

4.  Neonatal severe hyperparathyroidism: further clinical and molecular delineation.

Authors:  Fawziya A Al-Khalaf; Adel Ismail; Ashraf T Soliman; David E C Cole; Tawfeg Ben-Omran
Journal:  Eur J Pediatr       Date:  2010-10-23       Impact factor: 3.183

5.  Role for limited neck exploration in young adults with apparently sporadic primary hyperparathyroidism.

Authors:  Laura A Adam; Brian J Smith; Daniel Calva-Cerqueira; James R Howe; Geeta Lal
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

Review 6.  Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.

Authors:  Ogo I Egbuna; Edward M Brown
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

Review 7.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

Review 8.  Parathyroid hormone-dependent hypercalcemia.

Authors:  Judit Toke; Attila Patócs; Katalin Balogh; Péter Gergics; Balázs Stenczer; Károly Rácz; Miklós Tóth
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

9.  Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.

Authors:  Stephen J Marx; Ninet Sinaii
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

10.  Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation.

Authors:  Auryan Szalat; Michal Shahar; Shoshana Shpitzen; Boaz Nachmias; Gabriel Munter; David Gillis; Ronen Durst; Dror Mevorach; Eran Leitersdorf; Vardiella Meiner; Haim Rosen
Journal:  Endocrine       Date:  2014-08-05       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.